Analysts predict Pfizer's Q2 2024 revenue to be around $13 billion . The EPS estimate for Q2 2024 is $0.22, reflecting challenges from decreased COVID-19 product demand. Investors are closely watching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results